Objective: Device-associated infections in the central nervous system are serious complications of procedures involving indwelling devices among neurosurgical patients. In this study, the clinical characteristics and outcome of microbiologically confirmed deviceassociated cerebrospinal fluid (CSF) infection were evaluated. Methods: We performed a retrospective analysis of adult patients found to have a positive CSF culture result during a hospital admission between 1 January 2005 through 2 October 2010 in Soonchunhyang University Hospital. Results: During the study period, all episodes (n= 161 CSF specimens, 87 patients) involving a culture-positive CSF were enrolled. Thirty-two episodes of device-associated CSF infection were included in the analysis among the study group. Most device-associated infections were ventriculo-peritoneal shunt infections (14/32, 44%). Fever (> 38°C) was present in 17 episodes (53%). Overall, the most common microorganism was coagulase-negative staphylococcus (7/32 [22%]). Gram-negative rods (Pseudomonas aeruginosa 6/32 [19%], Acinetobacter baumannii/haemolyticus 5/32 [16%]) were identified in culture in 16/32 (50%). Device was removed for the control of device-associated infection in 30/32 (94%). Cure rate was 69% (22/32). All patients with treatment failure (10/32, 34%) expired. Conclusion: It is difficult to diagnosis device-associated CSF infections early since those are frequently presented with nonspecific clinical signs and symptoms. In our study, gram-negative infections accounted for 50% of cases and the empiric antibiotics initially chosen were found to not be effective against the final identified pathogen in many cases. Device-associated CSF infections should be strongly considered a serious risk factor associated with CSF infections, and prompt initiation of broad coverage antibiotics should be started after appropriate assessment.
INTRODUCTION
Device-associated infections of the central nervous system among neurosurgical patients include infectious complications of procedures such as intraventricular shunt operations, external ventricular drainage, external lumbar drainage, or cerebrospinal fluid (CSF) reservoir placement. A better understanding of device-associated infections is limited by the heterogeneity of cases (e.g., various neurosurgical procedures devices, different populations, etc.). Based on a recent literature review, the incidence of shunt-associated, external ventricular drainage-related, lumbar drainage-related, and Ommaya reservoir-related infections were found to be 1% to 18%, 2% to 27%, 7%, and 15%, respectively [1] [2] [3] [4] [5] [6] [7] [8] . Three of these studies used a clinical diagnosis to describe the characteristics of infection. We performed a retrospective analysis focused on episodes of microbiologically confirmed device-associated CSF infections in adult patients. In our study, we attempted to describe the clinical and microbiological characteristics and outcome of culture proven device-associated CSF infection.
MATERIALS AND METHODS
This retrospective study was conducted at a 705-bed tertiary hospital using medical records and the hospital's electronic laboratory database of adult patients admitted from 1 January 2005 through 2 October 2010. All cases with positive CSF culture results during the study period were identifed. We considered each individual case as a single episode if identical bacterial organisms Table   1 ). The main reason for device insertion was due to communicat- ing hydrocephalus (24/32, 75%). Most device-associated infection was ventriculo-peritoneal shunt infections (14/32, 44%) ( Table 2 ). Table 2 lists the neurological signs and symptoms at the time of device-associated CSF infection diagnosis. Fever (>38°C) was present in 17 episodes (53%), whereas headache (13%), nausea (9%), neck stiffness (3%) or decrease of Glasgow coma scale (19%) were less common. Local signs of infection were present in 3 episodes (9%) and included erythema, local pain, swelling, and/or purulent wound discharge. Nine episodes (28%) did not have fever or neurological signs or local manifestations of infection. Among those episodes, the most common pathogen was coagulase-negative staphylococci (3/9, 33%).
Clinical characteristics

Radiological characteristics
The cranial computed tomography (CT) scan was checked in 27
episodes. The CT scan showed findings of ventriculitis in 7% (2/27) and hematoma in 7% (2/27) of episodes. Meningitis or brain abscess was suspected in 15% (4/27). Among the 27 episodes, 8 (30%)
had cranial CT findings compatible with meningitis. Table 2 ).
Laboratory characteristics
Microbiologic findings
Overall, the most prevalent organism was coagulase-negative staphylococcus (7 [22%] of 32 episodes). Gram-negative rods were identified by culture in 16 (50%) of 32 episodes (Table 3) . (Table 4 ). Table 4 shows the treatment outcome at last follow-up. The cure Values are presented as number (%). ESBL, extended-spectrum β-lactamase.
Outcome
http://jsms.sch.ac.kr [12] . Traditionally, gram-positive microorganisms are the most common pathogens that cause intraventricular catheter related ventriculitis [13] . However, recent studies report a preponderance (range, 51% to 82%) of gram-negative infections [14, 15] , which are associated with a higher mortality rate (58%) in some studies [16] . Especially, acinetobacter spp. infection after neurosurgery is becoming an increasingly. It is related with high mortality due to its resistancy for carbapenem (72.5%) [17] . Our study also showed gram-negative rods in 50% of the device-associated CSF infections and they are associated with a higher mortality rates. And our result also showed highly proportion of resistant pathogen. 60% (3/5) of Acinetobacter baumannii/haemolyticus was carbapenem resistant. And all isolated Klebsiella pneumonia was ESBL producing-pathogen. Five patients with CSF infection due to this multidrug-resistant pathogen died.
Furthermore, the initial empiric antibiotic choice was inappropriate in many cases (18/32, 56%) due to increased gram negative bacteria (14/18, 88%) and multidrug-resistance (5/18, 28%). Therefore, broad spectrum antibiotics should be initially administered Values are presented as number (%). ESBL, extended-spectrum β-lactamase.
to patients at risk of infection caused by multidrug-resistant gramnegative bacteria.
Early recognition and aggressive treatment with coverage for gram-negative organisms and multidrug-resistant pathogens may improve the outcome for patients with device-associated CSF infections.
In conclusion, our results show the increased incidence of gramnegative bacteria as a causative pathogen associated with deviceassociated cerebrospinal fluid infection. To improve survival, it is necessary to make a timely diagnosis and initiate appropriate antibiotics according to risk for infection caused by multidrug-resistant pathogens. Given that the initial empiric antibiotic was inappropriate in most cases, a guideline accounting for the current epidemiology of etiologic bacteria in the context of changing empirical regimens is required.
